HomeTrading IdeasWhy Rising 401(k) Contributions...

Why Rising 401(k) Contributions Signal a Shift in Financial Priorities

Vanguard’s annual How America Saves report on trends in 401(K) and workplace retirement plan investing shows that investors are getting serious about saving.

One of the most notable statistics from the report is that the average deferral rate in 2024, meaning how much of an employee’s salary went to the 401(K) plan each month, was a record 7.7%.

In addition, 16% of participants increased their payroll deferral percentage, while just 8% decreased it. Further, an additional 29% saw their referral rate boosted via an automatic increase feature.

Overall, 45% of plan participants raised their savings rates in 2024 – an all-time high over the 24 years that Vanguard has conducted this survey, which pulled data from some 1,400 retirement plans serving more than 5 million participants.

“The report shows that, despite economic pressures and uncertainties, plan sponsors and participants continued to move forward in 2024,” Lauren Valente, managing director, Vanguard Workplace Solutions, said. “Sponsors and consultants leveraged the power of automatic solutions to drive participation rates to all-time highs. Additionally, widespread adoption of professionally managed allocations helped optimize participants’ age-based equity exposure—and resulted in more disciplined investing.

What Is the Average 401(k) Match?

The Vanguard report also revealed that 50% of Vanguard plans provided only a matching contribution, covering 52% of participants. Additionally, 36% of plans provided both a matching and a nonmatching employer contribution, covering 44% of participants. Further, 10% offered just a nonmatching contribution, serving 3% overall. Combined, some 96% of plans, covering 99% of participants, offered some type of match.

For context, matching contribution is when a plan matches a percentage of the employee’s contribution. The Vanguard survey found that among plans offering an employer match, 68% provided a single-tier match formula, while 25% offered multitier match formulas and 6% of plans imposed a maximum dollar cap on the employer contribution.

The most popular type of match formula, deployed by 13% of plans, was offering 50% on the first 6% of pay. Also, 10% offered 100% on the first 3% of pay, with 50% on the next 2% of pay. Further, 9% provided 100% match on the first 6% of pay, while 7% offered 100% on the first 5%, and 6% offered 100% on the first 4%.

The average match came out to 4.6% of pay, the same as 2023. But the average match has gradually climbed from 4.2% in 2015 to 4.6% now.

Also, according to Vanguard, nonmatching contributions are typically structured as a variable or fixed profit-sharing contribution or as an employee stock ownership plan (ESOP) contribution.

Participation in 401(K) and workplace retirement plans held steady at 85%, which is the same as 2023, but up from 81% in 2015. Participation has been helped over the years by the rise in plans that offer automatic enrollment. In 2024, 61% of plans offered autoenrollment, up from 59% in 2023 and just 41% in 2015.

A 13% Return in 2024

The survey found that the average account balance among those surveyed was $148,153, up 10% from the previous year.

The average return for 401(k) plan investors was 12.7% in 2024. Over the past three years, investors had an average annualized return of 5% and over the past 5 years they had an average annualized return of 8%.

Roughly 75% of overall assets were invested in equities, or stocks, with 42% in target date funds, 41% in diversified equity funds, and just 2% in company stock. Further, 3% of participants were in balanced funds, while 6% were in bond funds, and 5% were in cash.

Overall, the average plan offered 27.6 investment options. But most participants, 64%, only used one fund, while the average participant used 2.3 funds. Of the 64% only investing in one fund, 93% of them were in a single target date fund.

Also, some 67% of participants were invested in a professionally managed fund, an all-time high. Professionally managed allocations mostly refer to target-date funds, which base allocations on the expected retirement date. But they also include managed account advisory services.

The rise of target-date funds has led to less trading by participants. In 2024, only 5% of participants made a trade in their portfolio, that’s down from 10% in 2020.

Original Post

Most Popular

More from Author

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength...

Read Now

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody, for moderate-to-severe...

EUR/USD Slips as Trade Talks Stall and Retail Sales Disappoint

falls with trade talks in focus and following weak retail sales. Oil slips after OPEC+ increases output by more than expected.EUR/USD Falls With Trade Talks in Focus and After Weak Retail SalesThe EU and the US are nearing a framework agreement Eurozone retail sales fell -0.7% MoM EUR/USD...